Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

Sign up to receive Dr. Jay K. Varma’s reports in your inbox a day early. Hello and welcome to Healthbeat’s weekly report on ...

Her son had been sick for four months when Blanca Morales started asking about a transplant. It had started with a case of ...

A new study from the University of Birmingham has shown that fecal microbiota transplants (FMT) are highly successful in treating patients with Clostridioides difficile (C. diff) infection. A new ...

Mice fed a high-fat, high-protein diet were more likely to develop and die from antibiotic-driven Clostridioides difficile infections than mice fed a standard diet. In the same study, a ...

Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100% vaccine efficacy Median CDI duration was 1 versus ...

Clostridioides difficile infection is the leading cause of healthcare-associated infections, resulting in high rates of mortality, with upto 35% of patients experiencing recurrent infections.

EAST SYRACUSE, N.Y. (WSYR-TV) — The Upstate Institute for Global Health is looking for over 1,000 Central New Yorkers to participate in its largest clinical trial, testing a possible vaccine to ...

A possible cause of “sweet-smelling” stool is an Clostridioides difficile infection, which has several symptoms including diarrhea. “Sweet smelling” is not often a description associated with human ...

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive global license agreement with Valneva SE (Nasdaq: ...